RARE
Ultragenyx
14.90$
+3.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14.3% | +7.6% | +0.2% | -1.2% | +3.7% | -1.0% | -230.9% | – | +2.1% | -8.9% | +0.0% | – | |
| – | -3.2% | +9.4% | +6.6% | +5.6% | -3.4% | -0.6% | -3.5% | -3.9% | +0.8% | -19.5% | +13.3% | – | |
| – | +433.0% | -475.4% | – | +88.5% | -26.2% | -348.9% | – | – | -98.9% | -8,773.5% | – | – | |
| – | -56.7% | +725.7% | -65.9% | -64.1% | -59.6% | +2,396.0% | -23.2% | -89.8% | -26.6% | +6.6% | +0.0% | – | |
| – | -266.4% | – | -35.9% | -554.9% | – | +16.7% | -40.6% | +64.6% | -161.7% | -32.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,210.2% | -100.0% | – | -97.1% | -71.5% | -95.1% | +53,179.6% | -100.0% | +19,709,500.0% | – | – | – | |
| – | – | -168.9% | – | -189.7% | – | -287.8% | – | -47.3% | +750.8% | -213.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.